Women informed of over-detection risk less likely to want mammography
the ONA take:
According to a new study published in the journal The Lancet, researchers have found that women who are better informed about the risk of over-detection and over-diagnosis associated with mammography screening are less likely to have a breast cancer screening.
Mammography screening can prevent deaths associated with breast cancer, but most women are unaware that the screening can lead to over-diagnosis and overtreatment.
For the study, researchers randomly assigned 879 women aged 48-50 years who were about to become candidates for mammography screening to receive decision support materials with or without over-detection information.
Results showed that compared with controls, more women provided with over-detection information had adequate knowledge about breast cancer screening and made an informed choice about whether to be screened, had less favorable attitudes towards breast cancer screening, and had fewer intentions to be screened for breast cancer.
The findings suggest the importance of giving women clear decision support materials so that they can make more informed decisions about whether they should receive a mammography screening.
Women who are better informed about the risk of over-detection are less likely to have a breast cancer screening.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Neuropathic Cancer Pain Linked to Reduced Quality of Life
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|